omeprazole has been researched along with Poisoning in 3 studies
Omeprazole: A 4-methoxy-3,5-dimethylpyridyl, 5-methoxybenzimidazole derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits an H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS.
omeprazole : A racemate comprising equimolar amounts of (R)- and (S)-omeprazole.
5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole : A member of the class of benzimidazoles that is 1H-benzimidazole which is substituted by a [4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl group at position 2 and a methoxy group at position 5.
Poisoning: Used with drugs, chemicals, and industrial materials for human or animal poisoning, acute or chronic, whether the poisoning is accidental, occupational, suicidal, by medication error, or by environmental exposure.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To determine the effects of prostaglandin E(2) alone and the combination with omeprazole for poisoning related acute mucosal lesion." | 7.75 | [Prostaglandin E(2) and omeprazole in treating poisoning related acute mucosal lesion]. ( Fan, X; Xu, Y; Zhang, H, 2009) |
| "To determine the effects of prostaglandin E(2) alone and the combination with omeprazole for poisoning related acute mucosal lesion." | 3.75 | [Prostaglandin E(2) and omeprazole in treating poisoning related acute mucosal lesion]. ( Fan, X; Xu, Y; Zhang, H, 2009) |
| "Omeprazole is a commonly prescribed inhibitor of the gastric proton pump and has numerous indications in the treatment of gastrointestinal diseases." | 1.34 | Omeprazole-associated digoxin toxicity. ( Cragin, DJ; Kiley, CA; Roth, BJ, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fan, X | 1 |
| Xu, Y | 1 |
| Zhang, H | 1 |
| Forrester, MB | 1 |
| Kiley, CA | 1 |
| Cragin, DJ | 1 |
| Roth, BJ | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Proton Pump Inhibitors (PPI) as a New Strategy for Therapy in Sepsis: Clinical Trial to Reduce Severity of Organ Failure and in Vitro Experiments to Search Specific Hallmarks in Monocytes From Septic Patients and to Characterize the Mechanism of Action of[NCT03452865] | Phase 3 | 300 participants (Anticipated) | Interventional | 2020-01-28 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
3 other studies available for omeprazole and Poisoning
| Article | Year |
|---|---|
[Prostaglandin E(2) and omeprazole in treating poisoning related acute mucosal lesion].
Topics: Acute Disease; Animals; Dinoprostone; Enzyme Inhibitors; Female; Gastric Mucosa; Male; Omeprazole; O | 2009 |
Pattern of proton pump inhibitor calls to Texas poison centers, 1998-2004.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Animals; Child; Child, Preschool; Enzyme | 2007 |
Omeprazole-associated digoxin toxicity.
Topics: Aged; Atrial Fibrillation; Cardiotonic Agents; Digoxin; Drug Interactions; Enzyme Inhibitors; Female | 2007 |